| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Case of an Esophageal Cancer Patient Surviving for Over 4 Years After Chemoradiotherapy and Subsequent Chemotherapy
|
Misawa, M.
|
|
|
24 |
S9 |
p. ix78
|
article
|
| 2 |
A Case of Extra-Skeletal Ewing Sarcoma Elevated with Plasma Pro-GRP and Serum CA125
|
Yamamoto, S.
|
|
|
24 |
S9 |
p. ix72
|
article
|
| 3 |
A Case of Gastric Neuroendocrine Carcinoma with Cavernous Sinus Metastasis
|
Yoshizawa, K.
|
|
|
24 |
S9 |
p. ix92
|
article
|
| 4 |
A Case of Hodgkin Lymphoma Associated with Chronic Active EPSTEIN - BARR Virus Infection
|
Taniguchi, A.
|
|
|
24 |
S9 |
p. ix85
|
article
|
| 5 |
A Case of Metachronous Double Cancer of the Esophagus and Stomach
|
Kubo, H.
|
|
|
24 |
S9 |
p. ix78
|
article
|
| 6 |
A Case of Primary Plasma Cell Leukemia with a Favorable Response to Retreatment with Lenalidomide and Dexamethasone
|
Sawazaki, A.
|
|
|
24 |
S9 |
p. ix51
|
article
|
| 7 |
A Case of Undifferentiated Carcinoma of the Pancreas Showing Response to TC After Failure of GEM and S-1
|
Okazaki, S.
|
|
|
24 |
S9 |
p. ix79
|
article
|
| 8 |
A Case Report of a Primary Large-Cell Neuroendocrine Carcinoma of the Breast
|
Yoshimura, N.
|
|
|
24 |
S9 |
p. ix77
|
article
|
| 9 |
A Case Report; TS-1 and Docetaxcel Combination Therapy Result in the Good Outcome for Advanced Stomach Cancer Patient
|
Hasegawa, I.
|
|
|
24 |
S9 |
p. ix79
|
article
|
| 10 |
Achievements and Assignments of Regional Medical Corporation and Palliative Care Corporation in Our Hospital
|
Kamei, K.
|
|
|
24 |
S9 |
p. ix59
|
article
|
| 11 |
A Clinicopathological Analysis of Lymphoproliferative Disorders in Rheumatoid Arthritis
|
Kamogawa, Y.
|
|
|
24 |
S9 |
p. ix52
|
article
|
| 12 |
A Comparison of Four Methods for Detecting KRAS Mutations in Formalin-Fixed Colorectal Cancer Specimens
|
Miwa, K.
|
|
|
24 |
S9 |
p. ix54
|
article
|
| 13 |
Actions of the Symptom Control Research Group (SCORE-G) in the Palliative Care Field in Japan: Report 3
|
Tanda, S.
|
|
|
24 |
S9 |
p. ix66
|
article
|
| 14 |
Activity of a Chemotherapy Subcommittee with an Emphasis on Team Medical Care in Regional Medicine
|
Ueda, H.
|
|
|
24 |
S9 |
p. ix87
|
article
|
| 15 |
Actual Situation and Multifactorial Analysis of Standard Cancer Chemotherapy Regimen Use in Japan
|
Kawasumi, K.
|
|
|
24 |
S9 |
p. ix74
|
article
|
| 16 |
Additional Analysis of WJTOG0105 Comparing Second and Third-Generation Regimens with TRT in Unresectable Stage III NSCLC
|
Kaneda, H.
|
|
|
24 |
S9 |
p. ix62
|
article
|
| 17 |
A DLBCL Patient Accompanied by ITP Treated with R-CHOP and Thrombopoietin Receptor Agonist
|
Kurita, D.
|
|
|
24 |
S9 |
p. ix88
|
article
|
| 18 |
Advance Directives: Autonomy and End-of-Life Care in Korean Reality
|
Hong, J.H.
|
|
|
24 |
S9 |
p. ix67
|
article
|
| 19 |
Adverse Events Associated with GC Therapy for Urothelial Cancer
|
Kataoka, N.
|
|
|
24 |
S9 |
p. ix74
|
article
|
| 20 |
A Japanese Subgroup Analysis of the Lapatinib for Gastric Cancer (TYTAN) Study
|
Satoh, T.
|
|
|
24 |
S9 |
p. ix6
|
article
|
| 21 |
A Multicenter Phase II Study of Mogamulizumab (KW-0761) in Patients with Relapsed Peripheral or Cutaneous T-Cell Lymphoma
|
Hatake, K.
|
|
|
24 |
S9 |
p. ix36
|
article
|
| 22 |
A Multicenter Randomized Phase III Study of KRN125 (Pegfilgrastim) in Breast Cancer Patients Receiving TC Chemotherapy
|
Rai, Y.
|
|
|
24 |
S9 |
p. ix13
|
article
|
| 23 |
Analysis of Circulating Tumor EGFR-DNA in Plasma During EGFR-TKI Therapy of EGFR Mutation-Positive Lung Cancer Patients
|
Uchida, J.
|
|
|
24 |
S9 |
p. ix61
|
article
|
| 24 |
Analysis of Copy Number Aberration in Breast Cancer
|
Taira, F.
|
|
|
24 |
S9 |
p. ix50
|
article
|
| 25 |
Analysis of Definitive Chemoradiotherapy (CRT) in Each Clinical Stage for Elderly Patients with Esophageal Cancer
|
Ogawa, K.
|
|
|
24 |
S9 |
p. ix31
|
article
|
| 26 |
Analysis of Incidental Findings in FDG-PET/CT Examination for Cancer Care
|
Sasada, S.
|
|
|
24 |
S9 |
p. ix99
|
article
|
| 27 |
Analysis of 24 Patients with Carcinoma of Unknown Primary Site
|
Kudo, C.
|
|
|
24 |
S9 |
p. ix38
|
article
|
| 28 |
Analysis of Patients with Malignant Spinal Cord Compression at a Single Institution
|
Ichikawa, S.
|
|
|
24 |
S9 |
p. ix99
|
article
|
| 29 |
Analysis of the Breast Cancer Cases Aged More Than 85 Who Didn'T Undergo Surgery
|
Hasegawa, S.
|
|
|
24 |
S9 |
p. ix77
|
article
|
| 30 |
Analysis of the Frequencies of Accompanying Cancers in Multiple Primary Cancer Patients
|
Sumimoto, H.
|
|
|
24 |
S9 |
p. ix81
|
article
|
| 31 |
Analysis of the Incidence About Consultation At Emergency Room in Outpatients Receiving Cancer Treatment
|
Shibata, Y.
|
|
|
24 |
S9 |
p. ix57
|
article
|
| 32 |
Anaplastic Lymphoma Kinase Gene Copy Number Gain in Inflammatory Breast Cancer
|
Kim, M.H.
|
|
|
24 |
S9 |
p. ix25
|
article
|
| 33 |
An Autopsy Case Report of Double Cancer of Esophageal Cancer and Gastric Cancer Developed Various Metastases
|
Kitamura, H.
|
|
|
24 |
S9 |
p. ix78
|
article
|
| 34 |
An Effective Educational Strategy to Promote and Spread Team Medical Care and Regional Collaboration
|
Akiyama, S.
|
|
|
24 |
S9 |
p. ix22
|
article
|
| 35 |
ANTI-CD30 Antibody Drug Conjugate Therapy in Hodgkin Lymphoma and CD30+ Lymphoma
|
Chau, I.
|
|
|
24 |
S9 |
p. ix18
|
article
|
| 36 |
Antiemetic Effects by 1-Day Versus 3-Day Dexamethasone with Palonosetron Following Paclitaxel-Carboplatin Therapy
|
Watanabe, H.
|
|
|
24 |
S9 |
p. ix56
|
article
|
| 37 |
A Phase I and Dose-Finding Study of Lenvatinib (E7080) in Japanese Patients with Advanced Solid Tumors
|
Yamamoto, N.
|
|
|
24 |
S9 |
p. ix48
|
article
|
| 38 |
A Phase IB Trial of Ramucirumab (RAM), in Combination with Docetaxel (D) in Japanese Patients with Advanced Metastatic Breast Cancer (MBC)
|
Iwata, H.
|
|
|
24 |
S9 |
p. ix32
|
article
|
| 39 |
A Phase II Study of Cetuximab Plus Irinotecan/S-1 as First-Line Treatment in KRAS Wild-Type Metastatic Colorectal Cancer
|
Masuishi, T.
|
|
|
24 |
S9 |
p. ix41
|
article
|
| 40 |
A Phase II Study of Neoadjuvant Weekly Paclitaxel with and without Trastuzumab in Elderly Breast Cancer Patients
|
Sasaki, Y.
|
|
|
24 |
S9 |
p. ix60
|
article
|
| 41 |
A Phase II Study of the Panitumumab+ Irinotecan Therapy for Advanced / Recurrence Colorectal Cancer (Topic Study)
|
Denda, T.
|
|
|
24 |
S9 |
p. ix42
|
article
|
| 42 |
A Phase II Study On 3RD-Line Chemotherapy Combined Bevacizumab with S-1 for Colorectal Cancer with Mutated KRAS
|
Miyake, Y.
|
|
|
24 |
S9 |
p. ix41
|
article
|
| 43 |
A Phase 1 Study of Cabozantinib in Japanese Patients with Advanced Solid Tumors: Anti-Tumor Activity in NSCLC and GIST
|
Nokihara, H.
|
|
|
24 |
S9 |
p. ix48
|
article
|
| 44 |
A Phase 2 Study of Trastuzumab Emtansine in Japanese Patients with HER2 Positive Metastatic Breast Cancer
|
Takahashi, S.
|
|
|
24 |
S9 |
p. ix20
|
article
|
| 45 |
A Pleomorphic Carcinoma of the Lung with Small Intestinal Metastasis Producing Multiple Cytokines
|
Hara, S.
|
|
|
24 |
S9 |
p. ix94
|
article
|
| 46 |
A Randomized, Double-Blind, Placebo-Controlled PIII Study of Fentanyl Buccal Tablet (FBT) for Breakthrough Cancer Pain
|
Shinozaki, K.
|
|
|
24 |
S9 |
p. ix35
|
article
|
| 47 |
A Retrospective Analysis of Cancer of Unknown Primary in Ibaraki Prefectural Central Hospital
|
Fujisawa, F.
|
|
|
24 |
S9 |
p. ix38
|
article
|
| 48 |
A Retrospective Analysis of Elderly Patients with Acute Myeloid Leukemia
|
Seki, M.
|
|
|
24 |
S9 |
p. ix5
|
article
|
| 49 |
A Retrospective Analysis of First-Line Treatment in HER2-Positive and HER2-Negative Advanced Gastric Cancer
|
Onodera, K.
|
|
|
24 |
S9 |
p. ix66
|
article
|
| 50 |
A Retrospective Analysis of Long-Term Survivors with Metastatic Pancreatic Ductal Adenocarcinoma
|
Hayashi, H.
|
|
|
24 |
S9 |
p. ix47
|
article
|
| 51 |
A Retrospective Analysis of Neutropenia in Patients Receiving Concomitant Administration of Docetaxel and Clarithromycin
|
Kamezato, M.
|
|
|
24 |
S9 |
p. ix73
|
article
|
| 52 |
A Retrospective Analysis of 18 Patients with Advanced Thymic Carcinoma Who Received Chemotherapy at This Institution
|
Miura, Y.
|
|
|
24 |
S9 |
p. ix45
|
article
|
| 53 |
A Retrospective Analysis of 76 Patients with Malignancy who Were Referred to Department of Home Care Medicine
|
Hamaguchi, D.
|
|
|
24 |
S9 |
p. ix58
|
article
|
| 54 |
A Retrospective Analysis of the Risk Factors for Allergic Reactions Induced by the Administration of Oxaliplatin
|
Uoi, M.
|
|
|
24 |
S9 |
p. ix64
|
article
|
| 55 |
A Retrospective Comparison Study of Docetaxel and Paclitaxel for Previously Treated Chemotherapy for Esophageal Cancer
|
Shirakawa, T.
|
|
|
24 |
S9 |
p. ix57
|
article
|
| 56 |
A Retrospective Study of Reintroduction of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer
|
Nakayama, N.
|
|
|
24 |
S9 |
p. ix64
|
article
|
| 57 |
A Single-Center Retrospective Study of Chemotherapy in Patients with Small Cell Lung Cancer
|
Fujitani, Y.
|
|
|
24 |
S9 |
p. ix68
|
article
|
| 58 |
A Statistical Analysis on Clinical Implication of Bone Marrow Study: A Single Institute Data
|
Ho, J.J.
|
|
|
24 |
S9 |
p. ix86
|
article
|
| 59 |
A Study of Primary Untreated Japanese Mds Patients' Prognoses in the IPSS-R: the Results of a Single-Center Study
|
Adachi, Y.
|
|
|
24 |
S9 |
p. ix90
|
article
|
| 60 |
A Trimethoprim-Sulfamethoxazole May Regulate an Extension of the Treatment Interval in Patients Receiving Chemotherapy
|
Goto, T.
|
|
|
24 |
S9 |
p. ix34
|
article
|
| 61 |
A Workshop Promoting and Spreading Team Medical Care and Regional Collaboration for Cancer Patients
|
Akiyama, S.
|
|
|
24 |
S9 |
p. ix98
|
article
|
| 62 |
Bacteremia in Gastric Cancer Patients. -A Demographic Study-
|
Mikawa, T.
|
|
|
24 |
S9 |
p. ix67
|
article
|
| 63 |
Bendamustine Therapy for Relapsed or Refractory Low Grade B-Cell Lymphoma and Mantle Cell Lymphoma
|
Yamada, T.
|
|
|
24 |
S9 |
p. ix36
|
article
|
| 64 |
Benefit of High Dose Erlotinib for Suppression of Acquired Resistance in EGFR L858R-Mutated NSCLC Cells
|
Furugaki, K.
|
|
|
24 |
S9 |
p. ix69
|
article
|
| 65 |
Beyond EGFR and ALK Inhibition: New Promising Targeted Therapy for Lung Cancer
|
Wu, Y.-l.
|
|
|
24 |
S9 |
p. ix12
|
article
|
| 66 |
Biomarker Analysis of WJOG4107 (A Randomized Phase II Trial of Adjuvant Chemotherapy with S-1 vs CDDP + S-1 in NSCLC)
|
Takeda, M.
|
|
|
24 |
S9 |
p. ix63
|
article
|
| 67 |
BRAF, PIK3CA Alterations can Predict Outcomes to Cetuximab Contained Conversion Chemotherapy in Wild-Type KRAS CLM
|
Lin, Q.
|
|
|
24 |
S9 |
p. ix53
|
article
|
| 68 |
BTR May Be Useful Markers for Aggressive Therapy for Primary Hepatic Neuroendocrine Case with Jaundice
|
Ishikawa, T.
|
|
|
24 |
S9 |
p. ix95
|
article
|
| 69 |
Cancer of Unknown Primary Site: Review of Consecutive Cases in Aichi Cancer Center Hospital
|
Nitta, S.
|
|
|
24 |
S9 |
p. ix59
|
article
|
| 70 |
Can GRADE2 Neutropenia Predict the Risk of Grade3 Neutropenia in Colorectal Cancer Patients Treated with Chemotherapy?
|
Yoshida, Y.
|
|
|
24 |
S9 |
p. ix65
|
article
|
| 71 |
Case of Prolonged Bradycardia Induced by Bevacizumab-Associated Infusion Reaction in Advanced Metastatic Colon Cancer
|
Mori, Y.
|
|
|
24 |
S9 |
p. ix82
|
article
|
| 72 |
27 Cases of Paraneoplastic Autoimmune Thrombocytopenia in Solid Tumors
|
Jo, T.
|
|
|
24 |
S9 |
p. ix81
|
article
|
| 73 |
Challenges in the Development of Targeted Therapies Based on Molecular Characteristics in GI Cancers
|
Grothey, A.
|
|
|
24 |
S9 |
p. ix7
|
article
|
| 74 |
Challenges of Treating Patients with Cancer in Australia
|
Richardson, G.
|
|
|
24 |
S9 |
p. ix9
|
article
|
| 75 |
Changes in Quality of Life Through the Intervention by a Palliative Care Team for Patients with Advanced Lung Cancer
|
Yokoyama, T.
|
|
|
24 |
S9 |
p. ix58
|
article
|
| 76 |
Characteristics of Malignant Lymphoma and the Treatment Outcomes in Patients Aged 80 Years or Over at Our Institution
|
Iino, M.
|
|
|
24 |
S9 |
p. ix85
|
article
|
| 77 |
Characteristics of Non-Small Cell Lung Cancer with Rare Epidermal Growth Factor Receptor Gene Mutations
|
Namba, Y.
|
|
|
24 |
S9 |
p. ix44
|
article
|
| 78 |
Characterization of a Lung Cancer Growth Factor, LASEP3 as a Serological and Prognostic Biomarker and Therapeutic Target
|
Takano, A.
|
|
|
24 |
S9 |
p. ix49
|
article
|
| 79 |
Characterization of Patient with High Serum Level of IL-6 in Advanced Pancreatic Cancer
|
Miura, T.
|
|
|
24 |
S9 |
p. ix33
|
article
|
| 80 |
Chemotherapy with Docetaxel, Cisplatin and Capecitabine (DCX) for Advanced Gastric Cancer
|
Maeda, O.
|
|
|
24 |
S9 |
p. ix31
|
article
|
| 81 |
Circulating Tumor Cells as a Prognostic Marker in Metastatic Non-Small-Cell Lung Cancer Patients Receiving Chemotherapy
|
Sakamori, Y.
|
|
|
24 |
S9 |
p. ix82
|
article
|
| 82 |
Clinical Benefit of 2ND EGFR-TKI Retreatment on Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer
|
Nakashima, M.
|
|
|
24 |
S9 |
p. ix43
|
article
|
| 83 |
Clinical Course and Treatment Outcomes of Metastatic Colon Cancer Patients At a Medical Center for Respiratory Diseases
|
Hirashima, T.
|
|
|
24 |
S9 |
p. ix65
|
article
|
| 84 |
Clinical Demographics and Multimodal Therapy for Colorectal Cancer Patients with Human Immunodeficiency Virus Infection
|
Sumiyoshi, H.
|
|
|
24 |
S9 |
p. ix55
|
article
|
| 85 |
Clinical Features and Outcome of Hepatocellular Carcinoma Patients Without Etiologic Risk Factors
|
Shiba, S.
|
|
|
24 |
S9 |
p. ix33
|
article
|
| 86 |
Clinical Features and Outcome of Sporadic Colorectal Carcinoma in Young Adults: A Single Center, Cross Sectional Study
|
Zahir, M.N.
|
|
|
24 |
S9 |
p. ix93
|
article
|
| 87 |
Clinical Impact of Without Bevacizumab at First Several Cycle in 1st Line Chemotherapy of Colorectal Cancer: "Midway BV"
|
Sogabe, S.
|
|
|
24 |
S9 |
p. ix64
|
article
|
| 88 |
Clinical Investigation of Cisplatine/Pemetrexed in Patients with Advanced Non-Squamous Non-Small-Cell Lung Cancer
|
Watanabe, K.
|
|
|
24 |
S9 |
p. ix70
|
article
|
| 89 |
Clinical Phenotype of Microsatellite Instable Metastatic or Recurrent Colorectal Cancer in a Japanese Population
|
Takahashi, H.
|
|
|
24 |
S9 |
p. ix93
|
article
|
| 90 |
Clinical Significance of Peroxisome Proliferator-Activated Receptor Γ and MED1/TRAP220 in Patients with Operable Colorectal Cancer
|
Oh, S.Y.
|
|
|
24 |
S9 |
p. ix53
|
article
|
| 91 |
Clinical Trial Using Cancer/Testis Antigen- and/or VEGFR1/2-Derived Peptide-Vaccine Cocktails
|
Mori, T.
|
|
|
24 |
S9 |
p. ix48
|
article
|
| 92 |
Clinicopathologic Features Predicting HER2 Overexpression in Gastric Cancer
|
Park, J.S.
|
|
|
24 |
S9 |
p. ix15
|
article
|
| 93 |
CML-AP Taken the Adverse Event and the Mutation of ABL Kinase Into Consideration and Continued the Second Generation TKI
|
Tono, Y.
|
|
|
24 |
S9 |
p. ix76
|
article
|
| 94 |
Combination Therapy of Gemcitabine and 24-H Infusion of Cisplatin for Advanced Urothelial Carcinomas
|
Ina, K.
|
|
|
24 |
S9 |
p. ix71
|
article
|
| 95 |
Comparison Between Primary Tumor Resection and Primary Chemotherapy for Patients with Unresectable Colorectal Cancer
|
Yamauchi, M.
|
|
|
24 |
S9 |
p. ix55
|
article
|
| 96 |
Comparison of Docetaxel and Paclitaxel for Advanced Esophageal Cancer After Progression on Platinum-Based Chemotherapy
|
Ohori, H.
|
|
|
24 |
S9 |
p. ix78
|
article
|
| 97 |
Comt Genotype and Patients' Recognition of Pain Reduction are Predictive Markers for the Response to Morphine Treatment
|
Matsuoka, H.
|
|
|
24 |
S9 |
p. ix35
|
article
|
| 98 |
Construction of a 3D Culture Assay System for Anti-Cancer Drug Testing
|
Terashima, M.
|
|
|
24 |
S9 |
p. ix77
|
article
|
| 99 |
Continuation Maintenance Therapy with Pemetrexed(PEM) ± Bevacizumab(BEV) Following First Line Cisplatin/PEM ± BEV for NSCLC
|
Niwa, T.
|
|
|
24 |
S9 |
p. ix62
|
article
|
| 100 |
Cooperation with Other Clinical Departments in Intervention of Palliative Care Team in Our Hospital
|
Kawabata, H.
|
|
|
24 |
S9 |
p. ix67
|
article
|
| 101 |
Correlation of Malignancy and Sensitivity to Prior Treatment in Metastatic Breast Cancer Treated with Eribulin
|
Iwasa, T.
|
|
|
24 |
S9 |
p. ix32
|
article
|
| 102 |
Crizotinib Treatment in Patients (PTS) with Advanced ROS1-Rearranged Non-Small Cell Lung Cancer (NSCLC)
|
Ou, S.-H. I.
|
|
|
24 |
S9 |
p. ix43
|
article
|
| 103 |
Crizotinib vs. Pemetrexed or Docetaxel in Advanced Alk+ Non-Small Cell Lung Cancer: Subgroup Analysis in Profile 1007
|
Yamamoto, N.
|
|
|
24 |
S9 |
p. ix43
|
article
|
| 104 |
CTLS/Regulatory T-Cells Ratio as a Prediction Marker of Chemotherapy in Metastatic Colorectal Cancer
|
Sasatomi, T.
|
|
|
24 |
S9 |
p. ix93
|
article
|
| 105 |
Current Status of Comparative Effectiveness Research in the Us and Lessons Learned from Experience in Cancer Clinical Research
|
Setoguchi, S.
|
|
|
24 |
S9 |
p. ix23
|
article
|
| 106 |
Current Therapy Status for Lung Cancer in China
|
Wu, Y.-l.
|
|
|
24 |
S9 |
p. ix9
|
article
|
| 107 |
CVD Therapy for Unresectable Pheochromocytoma
|
Ando, T.
|
|
|
24 |
S9 |
p. ix96
|
article
|
| 108 |
Cytomegalovirus Antigenemia in the Patients of Lymphoid Malignancies
|
Sakamoto, T.
|
|
|
24 |
S9 |
p. ix68
|
article
|
| 109 |
Cytomegalovirus Esophagitis During Chemotherapy in Patients with Esophageal Cancer; a Report of Three Cases
|
Umemoto, K.
|
|
|
24 |
S9 |
p. ix78
|
article
|
| 110 |
Development of Cancer Specific Geriatric Assessment Japanese Version
|
Ogawa, A.
|
|
|
24 |
S9 |
p. ix34
|
article
|
| 111 |
Development of Personalized Medicine; Strategic Approach for Personalized Management in Advanced Gastric Cancer
|
Rha, S.Y.
|
|
|
24 |
S9 |
p. ix19
|
article
|
| 112 |
Development of Therapeutic Cancer Peptide Vaccines for Lung Cancer
|
Daigo, Y.
|
|
|
24 |
S9 |
p. ix29
|
article
|
| 113 |
Differential Treatment Strategies for Advanced Colorectal Cancer by Mutation Spectrum in the RAS-RAF Pathway and MSI
|
Inada, R.
|
|
|
24 |
S9 |
p. ix53
|
article
|
| 114 |
Diffuse Intrasinusoidal Liver Metastasis of Pancreatic Carcinoma Causing Fulminant Hepatic Failure
|
Kamihara, Y.
|
|
|
24 |
S9 |
p. ix99
|
article
|
| 115 |
Does Local Anesthetic Patch Reduce the Injection Site Pain of Fulvestrant in Postmenopausal Breast Cancer?
|
Yano, Y.
|
|
|
24 |
S9 |
p. ix90
|
article
|
| 116 |
Does the Use of Sorafenib for Advanced Hcc Follow Appropriate Selection Criteria?
|
Abdel-Rahman, O.M.
|
|
|
24 |
S9 |
p. ix71
|
article
|
| 117 |
DS12079 Displays Anticancer Activity Through Dual Inhibition on Topoisomerase and Hdac in PC-3 Cancer Cells
|
Yu, C.-C.
|
|
|
24 |
S9 |
p. ix97
|
article
|
| 118 |
Durable Response in Multiple Myeloma Patients Treated with Induction and Post-Transplantation Therapy with Novel Drugs
|
Ito, S.
|
|
|
24 |
S9 |
p. ix49
|
article
|
| 119 |
Early Palliative Care -The Current Situation in America
|
Shirai, K.
|
|
|
24 |
S9 |
p. ix11
|
article
|
| 120 |
Early Tumor Shrinkage as Predictor of Outcome in Colorectal Liver Metastases Treated with Cetuximab Plus Chemotherapy
|
Ye, L.
|
|
|
24 |
S9 |
p. ix14
|
article
|
| 121 |
Early Tumor Shrinkage in 1st-Line Treatment of Metastatic Colorectal Cancer Receiving mFOLFOX6 + Biweekly Cetuximab
|
Manaka, D.
|
|
|
24 |
S9 |
p. ix92
|
article
|
| 122 |
Editorial Board
|
|
|
|
24 |
S9 |
p. i-ii
|
article
|
| 123 |
Effectiveness of DA-EPOCH-R Therapy in Patient with Double Hit Lymphoma and Chronic Kidney Disease on Hemodialysis
|
Sugiyama, K.
|
|
|
24 |
S9 |
p. ix88
|
article
|
| 124 |
Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
|
Zhu, D.
|
|
|
24 |
S9 |
p. ix55
|
article
|
| 125 |
Effects of Zoledronic Acid on Renal Function in Patients with Malignant Tumor
|
Urakawa, H.
|
|
|
24 |
S9 |
p. ix73
|
article
|
| 126 |
Efficacy and Biomarker Analyses of Treatment with the Hedgehog Inhibitor, PF-04449913, in AML Cells
|
Fukushima, N.
|
|
|
24 |
S9 |
p. ix97
|
article
|
| 127 |
Efficacy and Safety of Chemotherapies for Advanced Non-Small Cell Lung Cancer Patients with Interstitial Pneumonia
|
Sakai, M.
|
|
|
24 |
S9 |
p. ix69
|
article
|
| 128 |
Efficacy and Safety of Gemcitabine Plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer
|
Oka, Y.
|
|
|
24 |
S9 |
p. ix34
|
article
|
| 129 |
Efficacy and Safety of Port Free Chemotherapy in Advanced Colorectal Cancer Patients
|
Matsuoka, H.
|
|
|
24 |
S9 |
p. ix75
|
article
|
| 130 |
Efficacy and Toxicity of Crizotinib for Patients with ALK-Positive Advanced NSCLC
|
Asao, T.
|
|
|
24 |
S9 |
p. ix94
|
article
|
| 131 |
Efficacy of Docetaxel for Non-Small-Cell Lung Cancer as Third-or-Later-Lines of Chemotherapy
|
Ebata, T.
|
|
|
24 |
S9 |
p. ix56
|
article
|
| 132 |
Effort of Patient Support Team for Chemotherapy in NHO National Toneyama Hospital
|
Nakatsuji, N.
|
|
|
24 |
S9 |
p. ix87
|
article
|
| 133 |
End of Life Care at a Gynecologic Oncology Unit
|
Hasumi, Y.
|
|
|
24 |
S9 |
p. ix84
|
article
|
| 134 |
Ethnic Differences in Lung Cancer : the Asian Perspective
|
Ahn, M.-J.
|
|
|
24 |
S9 |
p. ix9
|
article
|
| 135 |
Evaluating the Impact of MRP1 and MRP2 Polymorphisms on the Pharmacoresistance to Imatinib Treatment Among CML Patients
|
Au, A.
|
|
|
24 |
S9 |
p. ix76
|
article
|
| 136 |
Evaluation of Prophylactic Tetracyclines Use in Cetuximab Chemotherapy for Head and Neck Cancer
|
Yoshida, M.
|
|
|
24 |
S9 |
p. ix39
|
article
|
| 137 |
Evaluation of the G8 and Dementia Screening Tools for Frailty in Elderly Patients with Lung Cancer
|
Agemi, Y.
|
|
|
24 |
S9 |
p. ix87
|
article
|
| 138 |
Evaluation of UGT1A1 Genotyping for Predicting Individual Toxicity of Irinotecan Plus Platinum Analog Regimens
|
Takano, M.
|
|
|
24 |
S9 |
p. ix97
|
article
|
| 139 |
Examination of the Relevance Between the Weight Loss and the Prognosis in Advanced Lung Cancer Patients
|
Ota, K.
|
|
|
24 |
S9 |
p. ix81
|
article
|
| 140 |
Expression of Notch-1 in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
|
Xie, M.
|
|
|
24 |
S9 |
p. ix44
|
article
|
| 141 |
Extrapulmonary Small-Cell Carcinoma: A Single-Institution Experience
|
Watanabe, R.
|
|
|
24 |
S9 |
p. ix57
|
article
|
| 142 |
FDG-PET Scan and Serum NSE in Early Response to Sirolimus in Malignant Perivascular Epithelioid Cell Tumor (PEComa)
|
Gomi, D.
|
|
|
24 |
S9 |
p. ix73
|
article
|
| 143 |
Feasibility of Cancer Chemotherapy in Patients Who Undergo Dialysis Treatment
|
Sakaida, E.
|
|
|
24 |
S9 |
p. ix87
|
article
|
| 144 |
Feasibility of Exercise Therapy in Neutropenic Patients Undergoing Hematopoietic Stem Cell Transplantation
|
Tatematsu, N.
|
|
|
24 |
S9 |
p. ix58
|
article
|
| 145 |
Feasibility of Oxaliplatin Containing Regimens for Advanced Gastric Cancer (AGC) with Peritoneal Metastases
|
Komori, A.
|
|
|
24 |
S9 |
p. ix37
|
article
|
| 146 |
FIP1L1-PDGFRA +Ve Clonal Chronic Eosinophilic Leukemia; Low Burden Disease with Dramatic Response to Low Dose Imatinib
|
Kumar, A.
|
|
|
24 |
S9 |
p. ix52
|
article
|
| 147 |
First Experience of Active Surveillance Prior to Systemic Target Therapy in Patients with Metastatic Renal Cell Cancer
|
Matsubara, N.
|
|
|
24 |
S9 |
p. ix28
|
article
|
| 148 |
Fish Analysis for HEY1-NCOA2 Fusion Gene is Useful Diagnostic Tool for Mesenchymal Chondrosarcoma
|
Ono, K.
|
|
|
24 |
S9 |
p. ix72
|
article
|
| 149 |
Flare Phenomenon Following Gefitinib Treatment of Lung Cancer with Bone Metastasis
|
Kobayashi, S.
|
|
|
24 |
S9 |
p. ix86
|
article
|
| 150 |
Follow-Up of Reactivation of HB Virus in HBV Antibody Positive Lymphoma After Chemotherapy in a Single Institution
|
Igarashi, T.
|
|
|
24 |
S9 |
p. ix58
|
article
|
| 151 |
Foretinib Overcomes Resistance to Bevacizumab in a Novel in Vivo Model of Acquired Bevacizumab Resistance
|
Xie, M.
|
|
|
24 |
S9 |
p. ix97
|
article
|
| 152 |
Forty-One Cases of Metastases From Gastric Cancer to the Central Nerve System: Experience at a Single Institution
|
Shoji, H.
|
|
|
24 |
S9 |
p. ix37
|
article
|
| 153 |
Frequency of HPV Infection and EGFR, MAPK Pathway, and PIK3CA Mutation Profiles in SCC of the Cervical Esophagus
|
Masaru, F.
|
|
|
24 |
S9 |
p. ix79
|
article
|
| 154 |
Functional Characterization of Latent PDGFS Versus Activated PDGFS Induced by Proteolytic Processing
|
Li, H.
|
|
|
24 |
S9 |
p. ix59
|
article
|
| 155 |
Garenoxacin Prophylaxis for Febrile Neutropenia After Chemotherapy in Hematological Malignancies
|
Nakamura, N.
|
|
|
24 |
S9 |
p. ix34
|
article
|
| 156 |
Gastrointestinal Perforation by Bevacizumab
|
Miyamoto, S.
|
|
|
24 |
S9 |
p. ix81
|
article
|
| 157 |
GDP Chemotherapy for Relapsed/Refractory Lymphomas is Effective and Safe
|
Ouchi, A.
|
|
|
24 |
S9 |
p. ix89
|
article
|
| 158 |
Gemcitabine and Erlotinib in Patients with Advanced Pancreatic Cancer: Retrospective Single Institution Experience
|
Sakai, D.
|
|
|
24 |
S9 |
p. ix79
|
article
|
| 159 |
Gemcitabine Followed by Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer
|
Yasui, H.
|
|
|
24 |
S9 |
p. ix46
|
article
|
| 160 |
Genome-Wide Analysis for Methylation Status and Gene Expression of Melanomas and Melanocytes from the Same Individual
|
Fujiwara, S.
|
|
|
24 |
S9 |
p. ix77
|
article
|
| 161 |
Geriatric Assessment for the Elderly Patients with Diffuse Large B Cell Lymphoma (DLBCL) and Treatment Outcomes
|
Takamatsu, Y.
|
|
|
24 |
S9 |
p. ix36
|
article
|
| 162 |
Granulocyte Colony-Stimulating Factor (G-CSF) -Producing Metastatic Bone Tumors of the Unknown Primary Site
|
Yoneda, M.
|
|
|
24 |
S9 |
p. ix83
|
article
|
| 163 |
HER2I Resistance
|
Cascinu, S.
|
|
|
24 |
S9 |
p. ix17
|
article
|
| 164 |
How to Develop Molecular Targeted Drugs in Gastric Cancer: First or Second Line?
|
Moehler, M.
|
|
|
24 |
S9 |
p. ix15
|
article
|
| 165 |
How to Prolong Overall Survival with Maintaining Quality of Life
|
Lordick, F.
|
|
|
24 |
S9 |
p. ix15
|
article
|
| 166 |
How to Use Oral Fluoropyrimidine in Triplet or Doublet Therapy as the European Standard
|
Pfeiffer, P.
|
|
|
24 |
S9 |
p. ix15
|
article
|
| 167 |
Hydration in Four Hours Around the Cisplatin Infusion May Be Critical for Preventing Cisplatin-Induced Nephrotoxicity
|
Yamaguchi, T.
|
|
|
24 |
S9 |
p. ix80
|
article
|
| 168 |
Ibritumomab Tiuxetan is Safe and Highly Effective in the Elderly with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma
|
Uchida, T.
|
|
|
24 |
S9 |
p. ix85
|
article
|
| 169 |
Identification of Actionable Mutations in Specimens from Patients with Lung Cancer At Shizuoka Cancer Center
|
Kenmotsu, H.
|
|
|
24 |
S9 |
p. ix27
|
article
|
| 170 |
Impairment of Renal Function in the Breast Cancer Patients with Bone Metastases Treated with Zoledronic Acid
|
Ito, T.
|
|
|
24 |
S9 |
p. ix61
|
article
|
| 171 |
Incidence of Deep Vein Thrombosis (DVE) in Myeloma Patients Treated with Lenalidomide/ Dexamethasone with Prophylaxis
|
Nishimura, N.
|
|
|
24 |
S9 |
p. ix52
|
article
|
| 172 |
Influence of Rituximab Plus Bendamustine Chemotherapy on the Immune System in Lymphoma Patients
|
Ito, K.
|
|
|
24 |
S9 |
p. ix37
|
article
|
| 173 |
Infrastructural Capability of Investigator-Initiated Trials Involving Unapproved Investigational Drugs in Japan
|
Shimizu, T.
|
|
|
24 |
S9 |
p. ix24
|
article
|
| 174 |
Inhibition of Cancer Cell Proliferation by Color Modulation: A Pilot Study
|
Li, X.
|
|
|
24 |
S9 |
p. ix83
|
article
|
| 175 |
Initial Chemotherapy for Asymptomatic Brain Metastasis of Non-Small Cell Lung Cancer
|
Sekihara, K.
|
|
|
24 |
S9 |
p. ix70
|
article
|
| 176 |
Initial Evaluation of the Clinical Efficacy and Safety of Axitinib in Metastatic Renal Cell Carcinoma Patients
|
Miura, N.
|
|
|
24 |
S9 |
p. ix71
|
article
|
| 177 |
Intensive Chemotherapy for Metastatic Colorectal Cancer (MCRC)
|
Ychou, M.
|
|
|
24 |
S9 |
p. ix14
|
article
|
| 178 |
Interstitial Lung Disease (ILD) After Pleurodesis Against Malignant Pleural Effusion (MPE)
|
Yokoe, N.
|
|
|
24 |
S9 |
p. ix61
|
article
|
| 179 |
Introduction
|
|
|
|
24 |
S9 |
p. ix5
|
article
|
| 180 |
Introduction of Telephone Consultation Support System for Outpatients with Hepatocellular Carcinoma (NEXALINK)
|
Sakata, Y.
|
|
|
24 |
S9 |
p. ix99
|
article
|
| 181 |
Introduction of the Early Palliative Care Using Central Venous Access Port Device (Cv Port) in Patients with Lung Cancer
|
Hirashima, T.
|
|
|
24 |
S9 |
p. ix61
|
article
|
| 182 |
Investigation About Risk Factors of Profound Neutropenia by Amrubicin Hydrochloride Therapy for Small Cell Lung Cancer
|
Imai, C.
|
|
|
24 |
S9 |
p. ix46
|
article
|
| 183 |
Investigation and Prevention of Fosaprepitant-Induced Vascular Pain
|
Imazu, K.
|
|
|
24 |
S9 |
p. ix95
|
article
|
| 184 |
Investigator-Initiated Trial for PMDA Approval in Collaboration with the US NCI/CTEP
|
Imamura, C.K.
|
|
|
24 |
S9 |
p. ix24
|
article
|
| 185 |
Irsogladine Maleate Prevents Oral Candidiasis Associated with Radiotherapy in Patients with Head and Neck Cancer
|
Takase, H.
|
|
|
24 |
S9 |
p. ix91
|
article
|
| 186 |
Irsogladine Maleate Reduces Severe Oral Mucositis in Patients Receiving Definitive Chemoradiotherpy for HNSCC
|
Nomura, M.
|
|
|
24 |
S9 |
p. ix91
|
article
|
| 187 |
Is Triplet Superior to Doublet Chemotherapy in Advanced Gastric Cancer?
|
Wagner, A.D.
|
|
|
24 |
S9 |
p. ix15
|
article
|
| 188 |
Large B Cell Lymphoma Developing Hypoxia Without Explainable Computed Tomography Shadowreport of 2 Cases
|
Shiota, N.
|
|
|
24 |
S9 |
p. ix94
|
article
|
| 189 |
Lenalidomide Therapy in Patients with Relapsed/Refractory Multiple Myeloma
|
Okada, K.
|
|
|
24 |
S9 |
p. ix49
|
article
|
| 190 |
Locally Advanced Head and Neck Squamous Cell Carcinomas Treated with DCF (Docetaxel,Cisplatin,5-FU) Induction Chemotherapy
|
Taguchi, J.
|
|
|
24 |
S9 |
p. ix91
|
article
|
| 191 |
Long-Term Survival Following of Neoadjuvant Intraarterial Chemotherapy for Stage IIIB Cervical Cancer
|
Kawaguchi, R.
|
|
|
24 |
S9 |
p. ix37
|
article
|
| 192 |
Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema
|
Yomota, M.
|
|
|
24 |
S9 |
p. ix45
|
article
|
| 193 |
Maintenance Pemetrexed Outpatient Therapy Does Not Affect QOL in Patients with Nonsquamous Non-Small Lung Cancer
|
Ishiura, Y.
|
|
|
24 |
S9 |
p. ix90
|
article
|
| 194 |
Malignant Proliferative Disease of Leukocytes Preceded by Father-Son Psychic Traumatism
|
Sedlacek, J.
|
|
|
24 |
S9 |
p. ix75
|
article
|
| 195 |
May Diagnosis of Endometrial Cancer be a Sentinel Event?
|
Aihara, S.
|
|
|
24 |
S9 |
p. ix85
|
article
|
| 196 |
Medical Oncological Care in the US: Providing Regional Care in Northern Colorado
|
Scott, M.T.
|
|
|
24 |
S9 |
p. ix10
|
article
|
| 197 |
Medical Oncology Training Programs At the University of Texas MD Anderson Cancer Center Need for Clinical Cancer Biologists to Advance the Field of Medical Oncology
|
Ueno, N.T.
|
|
|
24 |
S9 |
p. ix10
|
article
|
| 198 |
Medical Staff Training Program for Assessment of Chemoradiotherapy-Induced Oral Mucositis in Head and Neck Cancer
|
Yurikusa, T.
|
|
|
24 |
S9 |
p. ix39
|
article
|
| 199 |
Mogamulizumab for Relapsed Adult T-Cell Leukemia-Lymphoma: A Single-Institute Experience
|
Sato, S.
|
|
|
24 |
S9 |
p. ix76
|
article
|
| 200 |
Mogamulizumab Treatment for Adult T Cell Leukemia at a Single Hospital
|
Ureshino, H.
|
|
|
24 |
S9 |
p. ix75
|
article
|
| 201 |
Molecular Mediators of Obesity-Induced Breast Cancer
|
Hudis, C.A.
|
|
|
24 |
S9 |
p. ix7
|
article
|
| 202 |
Molecular Targeted Drugs for Head and Neck Cancer
|
Vermorken, J.B.
|
|
|
24 |
S9 |
p. ix21
|
article
|
| 203 |
Multicenter Prospective Study in Elderly Patients Treated with DTX and BEV for Advanced Nonsquamous NSCLC: TORG1014
|
Hida, N.
|
|
|
24 |
S9 |
p. ix62
|
article
|
| 204 |
Multidisciplinary Treatment of Leptomeningeal Metastasis in Patients with Breast and Gastric Cancer
|
Mitsuya, K.
|
|
|
24 |
S9 |
p. ix40
|
article
|
| 205 |
Nephrotoxicity of Cisplatin Combination Chemotherapy for Thoracic Malignancy Patients with Comorbidities
|
Sato, K.
|
|
|
24 |
S9 |
p. ix30
|
article
|
| 206 |
Neuroendocrine Tumors of the Uterine Cervix; a Retrospective Review of 16 Cases
|
Okame, S.
|
|
|
24 |
S9 |
p. ix84
|
article
|
| 207 |
New Promising Agents/Combinations for Colorectal Cancer
|
Tabernero, J.
|
|
|
24 |
S9 |
p. ix8
|
article
|
| 208 |
New Strategies to Treat EGFR Kinase Inhibitor Resistant Cancers
|
Jänne, P.A.
|
|
|
24 |
S9 |
p. ix18
|
article
|
| 209 |
Nomogram for Prediction of Toxicities in Advanced Colorectal Cancer (ACRC) Treated with Irinotecan (IRI)-Based Regimens
|
Ichikawa, W.
|
|
|
24 |
S9 |
p. ix54
|
article
|
| 210 |
Non-Thiotepa-Based HDT and ASCT for Relapsed/Refractory Secondary Central Nervous System Lymphoma
|
Shimizu, I.
|
|
|
24 |
S9 |
p. ix89
|
article
|
| 211 |
Nsclc Treatment with Bevacizumab: A Retrospective Analysis of 32 Patients at a Single Center
|
Hong, H.
|
|
|
24 |
S9 |
p. ix70
|
article
|
| 212 |
Nurses Can Contribute to Safe Cancer Chemotherapy by the Design on Electric Charts to Evaluate Adverse Events
|
Matsumoto, R.
|
|
|
24 |
S9 |
p. ix87
|
article
|
| 213 |
Oral S-1 and Trasutuzumab for an Elderly Patient Affected with HER-2 Positive Adenocarcinoma of Unknown Primary
|
Takahashi, H.
|
|
|
24 |
S9 |
p. ix84
|
article
|
| 214 |
ORAOV1 is Amplified in Esophageal Squamous Cell Cancer and Related to Tumor Growth and Poorly Differentiated Tumor
|
Togashi, Y.
|
|
|
24 |
S9 |
p. ix60
|
article
|
| 215 |
Outcome of Anti-Egfr Antibody Therapy in Metastatic Colorectal Cancer with Low-Frequency Kras Mutations
|
Hikosaka, T.
|
|
|
24 |
S9 |
p. ix53
|
article
|
| 216 |
Outpatient Chemotherapy for Super Elderly Patients with Non-Hodgkin Lymphoma
|
Nishio, M.
|
|
|
24 |
S9 |
p. ix35
|
article
|
| 217 |
Paclitaxel-Resistant Recurrent Breast Cancer: A Case of Partial Response Due to Addition of Bevacizumab to Paclitaxel
|
Ishizuna, K.
|
|
|
24 |
S9 |
p. ix76
|
article
|
| 218 |
Palonosetron Improves Dietary Intake Compared to Granisetron in Patients Undergoing Highly Emetogenic Chemotherapy
|
Shibata, N.
|
|
|
24 |
S9 |
p. ix56
|
article
|
| 219 |
Patterns of Efficacy, Toxicity and Treatment Discontinuation in HCC Patients Receiving Capecitabine Monotherapy
|
Abdel-Rahman, O.M.
|
|
|
24 |
S9 |
p. ix72
|
article
|
| 220 |
Pazopanib for Advanced Soft Tissue Sarcoma
|
Takamori, H.
|
|
|
24 |
S9 |
p. ix73
|
article
|
| 221 |
PD-1 and FOXP3 Predicting the Response to Neoadjuvant-Chemotherapy_(NAC) of Breast Cancer
|
Sawada, T.
|
|
|
24 |
S9 |
p. ix50
|
article
|
| 222 |
Personalised Medicine: The UK Experience
|
Twelves, C.
|
|
|
24 |
S9 |
p. ix19
|
article
|
| 223 |
Personalized Therapy for Advanced Non-Small Cell Lung Cancer: From the Battle Trial to Master Protocols
|
Herbst, R.S.
|
|
|
24 |
S9 |
p. ix19
|
article
|
| 224 |
Pharmacokinetics (PK) of the Pan-Her Inhibitor Dacomitinib (D) in Subjects with Mild or Moderate Hepatic Impairment
|
O'Connell, J.
|
|
|
24 |
S9 |
p. ix69
|
article
|
| 225 |
Phase I/II Study of Amrubicin Combined with Nedaplatin (CDGP) in Untreated Non-Small-Cell Lung Cancer
|
Ogawara, D.
|
|
|
24 |
S9 |
p. ix55
|
article
|
| 226 |
Phase III Study of Crizotinib vs. Chemotherapy in Advanced ALK+ NSCLC: Patient-Reported Symptoms and Quality of Life
|
Nokihara, H.
|
|
|
24 |
S9 |
p. ix43
|
article
|
| 227 |
Phase II Study of Bevacizumab Plus CBDCA/PAC as First Line Chemotherapy for Non-SQ NSCLC with Malignant Pleural Effusion
|
Tamiya, M.
|
|
|
24 |
S9 |
p. ix63
|
article
|
| 228 |
Phase II Study of Palbociclib (PD-0332991) + Letrozole vs Letrozole Alone in First-Line ER + /HER2- Advanced Breast Cancer
|
Finn, R.S.
|
|
|
24 |
S9 |
p. ix32
|
article
|
| 229 |
Phase II Study of Panitumumab + IRI for Metastatic Colorectal Cancer with Wild KRAS, Resistant to IRI (OGSG1001)
|
Sugimoto, N.
|
|
|
24 |
S9 |
p. ix41
|
article
|
| 230 |
Phase II Study of Sunitinib (SU) in Japanese Patients with Well-Differentiated Pancreatic Neuroendocrine Tumor (NET)
|
Igarashi, H.
|
|
|
24 |
S9 |
p. ix82
|
article
|
| 231 |
PHASEII Study of S-1 with Irinotecan Combination Therapy for EGFR-Mutated NSCLC Resistant to EGFR-TKI: NJLCG0804
|
Nakano, K.
|
|
|
24 |
S9 |
p. ix44
|
article
|
| 232 |
Phase II Study of Tailored Dose S-1 Plus Carboplatin Followed by S-1 for Advanced Squamous Cell Lung Cancer
|
Yuh, N.
|
|
|
24 |
S9 |
p. ix62
|
article
|
| 233 |
Phase II Trial of mFOLFOX6/CapeOX Plus Bevacizumab with Oxaliplatin in a Stop and Go Fashion in Advanced mCRC
|
Gamoh, M.
|
|
|
24 |
S9 |
p. ix41
|
article
|
| 234 |
Phase II Trial of Temozolomide and Reirradiation Using Conformal Radiotherapy in Recurrent Brain Gliomas
|
Osman, M.A.
|
|
|
24 |
S9 |
p. ix40
|
article
|
| 235 |
Phase I Pharmacokinetic Study of S-1 Granule and Nedaplatin for Patients with Recurrent/Metastatic Head and Neck Cancer
|
Tanaka, K.
|
|
|
24 |
S9 |
p. ix40
|
article
|
| 236 |
Phase I Study of Amatuximab in Patients with Advanced Solid Tumors
|
Fujisaka, Y.
|
|
|
24 |
S9 |
p. ix49
|
article
|
| 237 |
Phase I Study of LY2523355, an EG5 Inhibitor, in Japanese Patients with Advanced Solid Tumors
|
Nakamichi, S.
|
|
|
24 |
S9 |
p. ix47
|
article
|
| 238 |
Phase I Study of Ombrabulin in Combination with Paclitaxel + Carboplatin Administered Every 3 Weeks to Japanese Patients
|
Matsumoto, K.
|
|
|
24 |
S9 |
p. ix47
|
article
|
| 239 |
Phase I Study of Patritumab (U3-1287) in Combination with Erlotinib in Japanese Patients with Non-Small Cell Lung Cancer
|
Murakami, H.
|
|
|
24 |
S9 |
p. ix55
|
article
|
| 240 |
Phase 3 Randomized Study (ARCHER 1050) of 1st-Line Dacomitinib vs Gefitinib for Advanced NSCLC with EGFR Mutation(S)
|
Mok, T.S.K.
|
|
|
24 |
S9 |
p. ix44
|
article
|
| 241 |
Phase 1 Study of MLN8237 (Alisertib) in Adult East Asian Patients (PTS) with Advanced Solid Tumors or Lymphomas
|
Kim, W.S.
|
|
|
24 |
S9 |
p. ix48
|
article
|
| 242 |
Photodynamic Effects of Epirubicin on Triple-Negative Breast Cancer Cells
|
Huang, Y.-H.
|
|
|
24 |
S9 |
p. ix94
|
article
|
| 243 |
PH 1 Study of PI3KMTOR Inhibitors PF-04691502 or PF-05212384 + MEK Inhibitor PD-0325901 or Irinotecan in Advanced Cancer
|
Britten, C.
|
|
|
24 |
S9 |
p. ix42
|
article
|
| 244 |
Platelet Transfusion During Chemotherapy-Induced Thrombocytopenia in Patients with Gynecologic Malignancy
|
Hashiguchi, Y.
|
|
|
24 |
S9 |
p. ix84
|
article
|
| 245 |
Potential Predictive Markers of Efficacy of Dacomitinib in Patients with Recurrent/Metastatic Scchn from a Phase 2 Trial
|
Soulieres, D.
|
|
|
24 |
S9 |
p. ix83
|
article
|
| 246 |
Predictive Molecular Markers of Imatinib Resistance and Prognosis in Chronic Myeloid Leukemia Patients
|
Elias, M.H.
|
|
|
24 |
S9 |
p. ix76
|
article
|
| 247 |
Present Status of Screening of Hepatitis B Virus Infection in Patients with Undergo Chemotherapy in Japan
|
Ikeda, M.
|
|
|
24 |
S9 |
p. ix74
|
article
|
| 248 |
Prevention of the Tumor Lysis-Associated Hyperuricemia by Rasburicase
|
Takaiwa, N.
|
|
|
24 |
S9 |
p. ix81
|
article
|
| 249 |
Preventive and Therapeutic Effects of Polaprezinc Suspension on Oral Mucosal Injury
|
Ishihama, H.
|
|
|
24 |
S9 |
p. ix68
|
article
|
| 250 |
Primary Angiosarcoma of the Aorta Found by EMBOLI of Left Femoral Artery: A Case Report
|
Matsumura, N.
|
|
|
24 |
S9 |
p. ix72
|
article
|
| 251 |
Primary Cardiac Lymphoma in Non-Immunocompromised Patients: Three Case Reports and Review of the Literature
|
Tabayashi, T.
|
|
|
24 |
S9 |
p. ix89
|
article
|
| 252 |
Primary HER2-Positive Lacrimal SAC Cancer
|
Ueda, H.
|
|
|
24 |
S9 |
p. ix84
|
article
|
| 253 |
Prognostic Factors in Unresectable Stage III Non-Small Cell Lung Cancer
|
Boku, S.
|
|
|
24 |
S9 |
p. ix96
|
article
|
| 254 |
Prognostic Impact of Central Nervous System Metastases and T790M Status After Acquired Resistance to EGFR-TKI
|
Hata, A.
|
|
|
24 |
S9 |
p. ix64
|
article
|
| 255 |
Psychosocial Problem in Families of Middle-Aged Cancer Patient Receiving Outpatient Chemotherapy
|
Asano, Y.
|
|
|
24 |
S9 |
p. ix58
|
article
|
| 256 |
Pulmonary Blastoma with Brain Metastasis Treated with Surgical Resection and Whole Brain Irradiation
|
Kawasaki, K.
|
|
|
24 |
S9 |
p. ix93
|
article
|
| 257 |
Quality of Life of Japanese Cancer Patients: A Nationally Representative Sample Survey Using Patient's Behavior Survey
|
Miyashita, M.
|
|
|
24 |
S9 |
p. ix35
|
article
|
| 258 |
Randomized Controlled Trial to Evaluate the Efficacy of Aprepitant in Hematological Malignancy
|
Nasu, R.
|
|
|
24 |
S9 |
p. ix51
|
article
|
| 259 |
Randomized Phase III Trial of Aprepitant Compared with Dexamethasone for Emesis Induced by Carboplatin
|
Daga, H.
|
|
|
24 |
S9 |
p. ix51
|
article
|
| 260 |
Randomized Study to Explore Indisetron for the Prevention of Acute-Onset Diarrhea, Nausea, Vomiting with IRIS/FOLFIRI
|
Iwanaga, I.
|
|
|
24 |
S9 |
p. ix95
|
article
|
| 261 |
Re-Challenge Treatment with Platinum-Containing Regimen in Patients with Sensitive Relapsed Small Cell Lung Cancer
|
Yamada, K.
|
|
|
24 |
S9 |
p. ix46
|
article
|
| 262 |
Rechallenge with EGFR-TKI after a Drug Holiday, Retrospective Study in Single Institution
|
Kodani, M.
|
|
|
24 |
S9 |
p. ix44
|
article
|
| 263 |
Reciprocal T(7;11)(P15;P15): A Rare but Recurrent Translocation in Acute Myeloid Leukemia. Report of 3 Cases
|
Manabe, M.
|
|
|
24 |
S9 |
p. ix52
|
article
|
| 264 |
Reconstruction After Total Gastrectomy in Patients with Gastric Cancer: Our Hospital Experience
|
Maksimovic, S.
|
|
|
24 |
S9 |
p. ix92
|
article
|
| 265 |
Reduction of Paclitaxel-Related Peripheral Sensory Neuropathy by Gosha-Jinki-Gan or Carbon Dioxide Feet and Hand Bathing
|
Kawabata, K.
|
|
|
24 |
S9 |
p. ix80
|
article
|
| 266 |
Reevesioside a Induces Anti-Proliferative Activity Through Cyclin Down-Regulation and G1 Arrest in PC-3 Cancer Cells
|
Leu, W.-J.
|
|
|
24 |
S9 |
p. ix98
|
article
|
| 267 |
Reevesioside F Induces Anticancer Activity Through Crosstalk Between ER Stress and Mitochondria Insult in Leukemia Cells
|
Chan, S.-H.
|
|
|
24 |
S9 |
p. ix98
|
article
|
| 268 |
Refusal of Chemotherapy: Adequacy of Decision Making by Patients
|
Kisohara, A.
|
|
|
24 |
S9 |
p. ix67
|
article
|
| 269 |
Regional Medical Liaison in Miyagi - The Problems and Our Activities
|
Akiyama, Shoko
|
|
|
24 |
S9 |
p. ix10
|
article
|
| 270 |
Relationship Between HER2 Expression and AFP Production in Gastric Cancer
|
Horita, Y.
|
|
|
24 |
S9 |
p. ix31
|
article
|
| 271 |
Relationship Between Hypertension and Proteinuria Associated with Bevacizumab : Retrospective Study on Cardiac Toxicity
|
Komori, K.
|
|
|
24 |
S9 |
p. ix57
|
article
|
| 272 |
Renal Toxicity of Pemetrexed in Patients with Non-Small-Cell Lung Cancer
|
Inoue, Y.
|
|
|
24 |
S9 |
p. ix69
|
article
|
| 273 |
Research on the Shift of Bone-Marrow-Suppression and the Use of G-CSF Due to FEC100 Treatment for Breast Cancer
|
Nakamura, K.
|
|
|
24 |
S9 |
p. ix67
|
article
|
| 274 |
Retrospective Analysis of Efficacy and Optional Treatment with Lapatinib Plus Capecitabine Therapy
|
Mizuno, Y.
|
|
|
24 |
S9 |
p. ix50
|
article
|
| 275 |
Retrospective Analysis of Induction Chemotherapy with Docetaxel, CDDP and S-1 Followed by CRT for Nasopharyngeal Cancer
|
Yamazaki, T.
|
|
|
24 |
S9 |
p. ix40
|
article
|
| 276 |
Retrospective Analysis of 29 Patients with Non-Squamous NSCLC Who Received Long-Term Treatment with Pemetrexed
|
Takahashi, S.
|
|
|
24 |
S9 |
p. ix86
|
article
|
| 277 |
Retrospective Analysis of Potential Risk of Denosumab-Induced Hypocalcemia in Solid Cancer Patients with Bone Metastases
|
Sato, Y.
|
|
|
24 |
S9 |
p. ix68
|
article
|
| 278 |
Retrospective Analysis of Re-Challenge of EGFR TK-IS in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer
|
Yoshino, R.
|
|
|
24 |
S9 |
p. ix96
|
article
|
| 279 |
Retrospective Analysis of Renal Function in Patients with Advanced Biliary Tract Cancer Treated by GC
|
Toyoda, M.
|
|
|
24 |
S9 |
p. ix34
|
article
|
| 280 |
Retrospective Cohort Study on the Safety and Efficacy of PMAB for MCRC Patients : Analysis of Clinical Early Predictor
|
Sato, Y.
|
|
|
24 |
S9 |
p. ix64
|
article
|
| 281 |
Retrospective Safety Analysis in Advanced Soft Tissue Sarcoma Patients of Pazopanib Hydrochloride
|
Kawasaki, K.
|
|
|
24 |
S9 |
p. ix38
|
article
|
| 282 |
Retrospective Study of Chemotherapy in Lung Cancer Patients Complicated Interstitial Pneumonia
|
Ueda, Y.
|
|
|
24 |
S9 |
p. ix70
|
article
|
| 283 |
Retrospective Study of L-Leucovorin and 5-FU Therapy in Gastric Cancer with Severe Ascites or Inadequate Oral Intake
|
Matsumoto, T.
|
|
|
24 |
S9 |
p. ix66
|
article
|
| 284 |
Retrospective Study of Treatment with S-1 Alone Or S-1 Plus Cisplatin in Elderly Patients with Advanced Gastric Cancer
|
Makiyama, C.
|
|
|
24 |
S9 |
p. ix31
|
article
|
| 285 |
Risk Factors for Late-Onset Neutropenia After Rituximab Treatment; a Retrospective Analysis at a Single Institution
|
Arai, Y.
|
|
|
24 |
S9 |
p. ix36
|
article
|
| 286 |
Risk Factors of Prolonged Hospitalization in Locally Advanced Head and Neck Cancer Patients with CCRT
|
Sato, Y.
|
|
|
24 |
S9 |
p. ix91
|
article
|
| 287 |
Risk Factors of Untransplantable Recurrence After Primary Curative Resection for Patients with Hepatocellular Carcinoma
|
Ho, C.-M.
|
|
|
24 |
S9 |
p. ix33
|
article
|
| 288 |
R497K are Associated with PFS and OS to EGFR TKIs in NSCLC Patient
|
Kang, J.H.
|
|
|
24 |
S9 |
p. ix45
|
article
|
| 289 |
Role of Targeted Therapy in the Treatment of Primary Breast Cancer
|
Zardavas, D.
|
|
|
24 |
S9 |
p. ix13
|
article
|
| 290 |
Ruptured Hepatocellular Carcinoma Following Transcatheter Arterial Chemoembolization: Two Rare Experiences
|
Morii, K.
|
|
|
24 |
S9 |
p. ix72
|
article
|
| 291 |
Safety Analysis of Sorafenib in Elderly Patients with Unresectable Advanced Hepatocellular Carcinoma
|
Goto, T.
|
|
|
24 |
S9 |
p. ix71
|
article
|
| 292 |
Safety and Efficacy of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer: A Subgroup Analysis of the Phase III Correct Trial
|
Yamada, Y.
|
|
|
24 |
S9 |
p. ix49
|
article
|
| 293 |
Safety and Tolerability of XELOX as an Adjuvant Therapy for STAGE2/3 Colorectal Cancer in a High Risk of Recurrence
|
Osawa, H.
|
|
|
24 |
S9 |
p. ix54
|
article
|
| 294 |
Safety and Tolerance of Oral Rehydration Solution (ORS) for Cisplatin-Based Chemotherapy in Patients with Lung Cancer
|
Yokoyama, T.
|
|
|
24 |
S9 |
p. ix80
|
article
|
| 295 |
Safety of Continuing Combination Antiretroviral Therapy During Chemotherapy in HIV-Infected Patients with Malignancies
|
Nakamura, A.
|
|
|
24 |
S9 |
p. ix74
|
article
|
| 296 |
Safety Profile of Chemotherapy with Docetaxel and Cisplatin for Recurrent or Metastatic Head and Neck Cancer
|
Shimada, T.
|
|
|
24 |
S9 |
p. ix39
|
article
|
| 297 |
Salvage Nogitecan Chemotherapy for Relapsed Small-Cell Lung Cancer
|
Hiyoshi, Y.
|
|
|
24 |
S9 |
p. ix69
|
article
|
| 298 |
Search for the Therapeutic Target of Met Inhibitor in Lung Cancer
|
Sugano, T.
|
|
|
24 |
S9 |
p. ix61
|
article
|
| 299 |
Second-Line Chemotherapy by Folfirinox with Unresectable Pancreatic Cancer (Phase I, II Study)
|
Kobayashi, N.
|
|
|
24 |
S9 |
p. ix46
|
article
|
| 300 |
Second-Line Therapy of S-1 for Patients with Advanced Biliary Tract Cancer After Failure to Cisplatin Plus Gemcitabine
|
Kobayashi, S.
|
|
|
24 |
S9 |
p. ix33
|
article
|
| 301 |
Serum Alpha-Fetoprotein (AFP) Level is a Prognostic Factor for Advanced Gastric Cancer?
|
Kobayashi, Y.
|
|
|
24 |
S9 |
p. ix91
|
article
|
| 302 |
Serum HER2ECD Levels in Patients with Advanced Gastric Cancer Treated with Trastuzumab as First-Line Therapy
|
Takahashi, M.
|
|
|
24 |
S9 |
p. ix92
|
article
|
| 303 |
Serum HER2 Extracellular Domain Levels and Tissue HER2 Overexpression in Advanced Gastric Cancer Patients
|
Takahashi, Y.
|
|
|
24 |
S9 |
p. ix31
|
article
|
| 304 |
Serum HER2 in Gastric Cancer
|
Saito, M.
|
|
|
24 |
S9 |
p. ix31
|
article
|
| 305 |
Severe Iron-Deficiency Anemia Diagnosed as Having Malignant Melanoma of Unknown Origin
|
Nishioka, K.
|
|
|
24 |
S9 |
p. ix83
|
article
|
| 306 |
Significance of Renal Mass Biopsy for Deciding the Treatment Strategy of Renal Tumor
|
Hori, J.-i.
|
|
|
24 |
S9 |
p. ix70
|
article
|
| 307 |
Significance of the Hospital Which Has Medical Treatment Ward in the End of Life Care of Lung Cancer
|
Kato, K.
|
|
|
24 |
S9 |
p. ix82
|
article
|
| 308 |
S-1 + Oxaliplatin as an Adjuvant Chemotherapy for Patients with Curative Resection of Double Cancer of Stomach and Rectum
|
Kobayashi, K.
|
|
|
24 |
S9 |
p. ix66
|
article
|
| 309 |
Study of Impact on the Quality of Life After Radiochemotherapy of Locally Advanced Anal Canal Carcinoma
|
Kumbhaj, D. p.
|
|
|
24 |
S9 |
p. ix75
|
article
|
| 310 |
Subcutaneous Implantation Type Central Veins Port (CV Port) Management in Patients with Malignant Tumor
|
Sato, J.
|
|
|
24 |
S9 |
p. ix96
|
article
|
| 311 |
Subgroup Analysis of Asian Patients in the Phase III Trial (GRID) of Regorafenib in Pretreated Metastatic GIST
|
Kang, Y.-K.
|
|
|
24 |
S9 |
p. ix6
|
article
|
| 312 |
Successful Treatment of a Hemodialysis Patient Using MFOLFOX-6/Bevacuzumab
|
Hayashi, M.
|
|
|
24 |
S9 |
p. ix81
|
article
|
| 313 |
Successful Treatment of Intravascular Large B-Cell Lymphoma with Combination of Chemotherapy and it Followed by ASCT
|
Makiyama, J.
|
|
|
24 |
S9 |
p. ix88
|
article
|
| 314 |
Successful Treatment of Malignant Pleural Mesothelioma with Cisplatin and Gemcitabine in a Hemodialysis Patient
|
Saida, Y.
|
|
|
24 |
S9 |
p. ix46
|
article
|
| 315 |
Suppression of PI3K-Akt-mTOR Signaling Pathway in Paradoxical EGF-Induced Cell Death
|
Hong-Gyun, W.
|
|
|
24 |
S9 |
p. ix59
|
article
|
| 316 |
Surrogate Markers of Survival in Locally Advanced Non-Small Cell Lung Cancer: Meta-Analysis from Randomized Trials
|
Akamatsu, H.
|
|
|
24 |
S9 |
p. ix63
|
article
|
| 317 |
Survey of Pharmacists' Involvement in Cancer Treatment in Cancer Medicine Cooperation Base and General Hospitals
|
Sakurai, H.
|
|
|
24 |
S9 |
p. ix73
|
article
|
| 318 |
Synergistic Interaction Betweem Olaparib, a Parp Inhibitor, and Cytotoxic Agent in Triple Negative Breast Cancer
|
Hashimoto, J.
|
|
|
24 |
S9 |
p. ix59
|
article
|
| 319 |
Table of Contents
|
|
|
|
24 |
S9 |
p. iv
|
article
|
| 320 |
Testicular and Leptomeningeal Relapse as Myeloid Sarcoma in a Patient Initially Diagnosed with T Lymphoblastic Lymphoma
|
Ueda, R.
|
|
|
24 |
S9 |
p. ix89
|
article
|
| 321 |
The Action of Manual Making and Team Approach for Using Denosumab in the Bone Metastasis Case
|
Tamiya, M.
|
|
|
24 |
S9 |
p. ix88
|
article
|
| 322 |
The Bronchoscopy-Guided Re-Biopsy of Non-Small Cell Lung Cancer in Patients Who Relapse After Gefitinib Therapy
|
Okamoto, N.
|
|
|
24 |
S9 |
p. ix96
|
article
|
| 323 |
The Clinical Features of Branch Duct Type Ipmns of the Pancreas with Classification of Histological Subtypes
|
Tanioka, H.
|
|
|
24 |
S9 |
p. ix47
|
article
|
| 324 |
The Combination Chemotherapy of Carboplatin and Weekly Paclitaxel Plus Bevacizumab in Patients with Advanced NSCLC
|
Kitaguchi, S.
|
|
|
24 |
S9 |
p. ix56
|
article
|
| 325 |
The Effect and Tolerability of MTOR Inhibitors for Metastatic Renal Cell Carcinoma
|
Tamada, S.
|
|
|
24 |
S9 |
p. ix71
|
article
|
| 326 |
The Effect of Nadroparin and Intraportal Infusion of Tegafur on Prevent Liver Metastasis After Colorectal Cancer Surgery
|
Chang, W.
|
|
|
24 |
S9 |
p. ix42
|
article
|
| 327 |
The Efficacy of Chemotherapy for Elderly Colorectal Cancer Patients Aged 75 or Over is Limited
|
Nakamura, M.
|
|
|
24 |
S9 |
p. ix65
|
article
|
| 328 |
The Evolving Treatment Paradigm for Neuroendocrine Tumours: The Asian Perspective
|
Lim, H.Y.
|
|
|
24 |
S9 |
p. ix9
|
article
|
| 329 |
The Impact of Counseling on Prevention Program in Saga Prefecture for Mother-to-Child Transmission of HTLV-1
|
Tsuge, K.
|
|
|
24 |
S9 |
p. ix98
|
article
|
| 330 |
The Influence of Body Mass Index on Severe Neutropenia with Dose-Dense Paclitaxel/Carboplatin in Ovarian Cancer Patients
|
Takase, N.
|
|
|
24 |
S9 |
p. ix38
|
article
|
| 331 |
The Influence of KRAS Mutation Analysis Before Primary Chemotherapy for Unresectable and Recurrent Colorectal Cancer
|
Satake, H.
|
|
|
24 |
S9 |
p. ix92
|
article
|
| 332 |
The Long Lasting Lesion of Acute Methotrexate-Induced Encephalopathy Detected by Diffusion-Weighted MRI
|
Nakagawa, M.
|
|
|
24 |
S9 |
p. ix86
|
article
|
| 333 |
The Modified PNA-LNA PCR Clamp Method for the Detection of EGFR Mutations in Non-Small Cell Lung Cancer
|
Tanai, C.
|
|
|
24 |
S9 |
p. ix82
|
article
|
| 334 |
The Optimal Treatment for Familial Breast Cancer Patients
|
Takuwa, H.
|
|
|
24 |
S9 |
p. ix60
|
article
|
| 335 |
The Outcome of Lung Cancer Patients Combined with Interstitial Lung Disease Treated with Palliative Chemotherapy
|
Choi, M.K.
|
|
|
24 |
S9 |
p. ix95
|
article
|
| 336 |
Therapeutic Drug Monitoring of Docetaxel for a Living Donor Liver Transplantation Recipient
|
Kawaguchi, K.
|
|
|
24 |
S9 |
p. ix94
|
article
|
| 337 |
Therapeutic Effect of Taxane for the Metastatic and Recurrent Breast Cancer in Intrinsic Subtypes
|
Fukada, I.
|
|
|
24 |
S9 |
p. ix32
|
article
|
| 338 |
Therapeutic Potential of Angiogenesis Inhibitors for Gastric Cancer
|
Goldstein, D.
|
|
|
24 |
S9 |
p. ix8
|
article
|
| 339 |
The Result of DOP (Dexamethasone, Vincristine, Pepleomycin) as Palliative Chemotherapy for Refractory/Relapsed Lymphoma
|
Takahashi, T.
|
|
|
24 |
S9 |
p. ix88
|
article
|
| 340 |
The Results of T-Cell Acute Lymphoblastic Leukemia/Lymphoma in Our Institute
|
Ueda, T.
|
|
|
24 |
S9 |
p. ix86
|
article
|
| 341 |
The Risk Factors for Bleomycin Pulmonary Toxicity for Hodgkin Lymphoma and Germ-Cell Tumor: A Single-Center Analysis
|
Yamada, Y.
|
|
|
24 |
S9 |
p. ix39
|
article
|
| 342 |
The Role of Bone-Modifying Agents (BMA) in the Treatment of Bone Metastases
|
Coleman, R.E.
|
|
|
24 |
S9 |
p. ix26
|
article
|
| 343 |
The Role of HER3 Expression and PTEN Loss in Patients with HER2-Overexpressing Metastatic Breast Cancer (MBC)
|
Park, Y.H.
|
|
|
24 |
S9 |
p. ix50
|
article
|
| 344 |
The Role of Indoleamine 2,3-Dioxygenase in Hepatocellular Carcinoma
|
Nagano, J.
|
|
|
24 |
S9 |
p. ix77
|
article
|
| 345 |
The Treatments Against Chemotherapy-Induced Glucose Intolerance
|
Suyama, H.
|
|
|
24 |
S9 |
p. ix80
|
article
|
| 346 |
The Utility of MGPS in the Prognostic Factor of the Patients with Unresectable Colorectal Cancer
|
Sakamoto, Y.
|
|
|
24 |
S9 |
p. ix54
|
article
|
| 347 |
Thrombosis by Totally Implantable Central Venous Access System in the Upper ARM: 3FR Catheter Cases
|
Murakawa, Y.
|
|
|
24 |
S9 |
p. ix80
|
article
|
| 348 |
Title Page
|
|
|
|
24 |
S9 |
p. iii
|
article
|
| 349 |
Tolerability of Standard Dose of Platinum-Based Chemotherapy in Fit Elderly Patients with Non-Small Cell Lung Cancer
|
Zenke, Y.
|
|
|
24 |
S9 |
p. ix63
|
article
|
| 350 |
Total Cancer Care in Community Medicine by Medical Oncologists
|
Okada, Y.
|
|
|
24 |
S9 |
p. ix98
|
article
|
| 351 |
Toxicities Can Be a Surrogate Predictive Marker for Lapatinib Efficacy in Patients with HER2 Positive Breast Cancer
|
Araki, K.
|
|
|
24 |
S9 |
p. ix50
|
article
|
| 352 |
Transformed Follicular Lymphoma Mimicking Acute Lymphoblastic Leukemia
|
Ohmoto, A.
|
|
|
24 |
S9 |
p. ix89
|
article
|
| 353 |
Treatment of Human Breast Cancer with Trastuzumab Can Potentially be Directed by Level of PDGF-Beta Receptor in Tumors
|
Liu, T.
|
|
|
24 |
S9 |
p. ix51
|
article
|
| 354 |
Treatment of Refractory or Relapsed AML with Gemutuzumab Ozogamicin Combined with Arac-Based Chemotherapy
|
Meshihtsuka, S.
|
|
|
24 |
S9 |
p. ix52
|
article
|
| 355 |
Treatment Strategy for Metastatic Colorectal Cancer in EU
|
Bodoky, G.
|
|
|
24 |
S9 |
p. ix14
|
article
|
| 356 |
Tumor Lysis Syndrome in Malignant Lymphoma, a Retrospective Study
|
Nasu, K.
|
|
|
24 |
S9 |
p. ix37
|
article
|
| 357 |
Two Cases of the MTX-LPD with Aggressive Clinical Course
|
Fujii, S.
|
|
|
24 |
S9 |
p. ix90
|
article
|
| 358 |
Two-Week Course of Preoperative Chemoradiotherapy for Rectal Cancer: A Phase II Multi-Institutional Clinical Trial
|
Lee, J.H.
|
|
|
24 |
S9 |
p. ix42
|
article
|
| 359 |
UGT1A1*28 Polymorphism and Vomiting in Advanced Colorectal Cancer
|
El Bastawisy, A.E.
|
|
|
24 |
S9 |
p. ix65
|
article
|
| 360 |
Ultrasound-Guided Central Venous Port Implantation in the Upper Arm
|
Shiono, M.
|
|
|
24 |
S9 |
p. ix95
|
article
|
| 361 |
Up-Front Autologous Stem Cell Transplantation for Elderly Patients with Diffuse Large B-Cell Lymphoma
|
Kaneko, H.
|
|
|
24 |
S9 |
p. ix85
|
article
|
| 362 |
Usefulness of the Treatment Algorithm for Oxaliplatin-Induced Peripheral Neuropathy
|
Nihei, S.
|
|
|
24 |
S9 |
p. ix79
|
article
|
| 363 |
Use of Genomics to Guide Therapy for Patients with Non-Small Cell Lung Cancer
|
Jänne, P.A.
|
|
|
24 |
S9 |
p. ix7
|
article
|
| 364 |
Utility of MRI and us for Evaluation of Minor Residual Diseases After Receiving Neoadjuvant Therapies to Breast Cancer
|
Kido, H.
|
|
|
24 |
S9 |
p. ix60
|
article
|
| 365 |
Validation of a New Epigenetic-Based Prognostic Blood Test to Predict Prostate Cancer Aggressiveness
|
Pchejetski, D.
|
|
|
24 |
S9 |
p. ix39
|
article
|
| 366 |
What is the Best Sequence of Targeted Agents in the Management of Advanced Colorectal Cancer
|
Sobrero, A.
|
|
|
24 |
S9 |
p. ix8
|
article
|
| 367 |
Which Do Patients with NSCLC Harboring EGFR Mutation Prefer EGFR-TKI or Chemotherapy? a Vignettes Study (LOGIK0903)
|
Fukuda, M.
|
|
|
24 |
S9 |
p. ix45
|
article
|
| 368 |
Whole-Exome Sequencing (WES) Using Formalin-Fixed Paraffin Embedded (FFPE) Tissue
|
Ouchi, K.
|
|
|
24 |
S9 |
p. ix93
|
article
|
| 369 |
WT1 Peptide Vaccine for Non-Small Lung Cancer After Operation
|
Sugiyama, H.
|
|
|
24 |
S9 |
p. ix29
|
article
|
Journal description